UBS Oncology Impact Fund L.P.

10% owner, Werewolf Therapeutics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$0.1M

Companies

Latest trade

Dec 1, 2025

Companies

Werewolf Therapeutics, Inc.10% owner −$0.6M

Trades

HOWL Sold 60,917 shares at $0.94 · planned $0.1M Dec 1

HOWL Sold 20,277 shares at $0.99 · planned $0.0M Nov 28

HOWL Sold 60,733 shares at $0.98 · planned $0.1M Nov 26

HOWL Sold 134,240 shares at $1.55 · planned $0.2M Oct 29

HOWL Sold 69,068 shares at $1.64 · planned $0.1M Oct 28

HOWL Sold 72,709 shares at $1.72 · planned $0.1M Oct 27

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.